Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 4,043 shares at $50.01 ($202K) on 2024-02-14, disclosed to the SEC on 2024-02-15.
Scheduled sale ($202k) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 1,865 | $93K | 46.1% |
| 2 | $50.01 | 1,089 | $54K | 26.9% |
| 3 | $50.01 | 1,089 | $54K | 26.9% |
| Total | $50.01 avg | 4,043 | $202K | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |